European Heart Journal

European Heart Journal 2001 22(23):2171-2179; doi:10.1053/euhj.2001.2822
Copyright © 2001 by the European Society of Cardiology.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (191) Request Permissions Google Scholar Articles by Anderson, L.J. Articles by Pennell, D.J. Search for Related Content PubMed PubMed Citation Articles by Anderson, L.J. Articles by Pennell, D.J. Social Bookmarking          What's this?

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

L.J. Anderson^a, S. Holden^b, B. Davis^b, E. Prescott^c, C.C. Charrier^a, N.H. Bunce^a, D.N. Firmin^a, B. Wonke^c, J. Porter^b, J.M. Walker^b and D.J. Pennell^a,f1

^a Cardiovascular MR Unit, Royal Brompton Hospital, London, U.K.
^b University College Hospital, London, U.K.
^c Whittington Hospital, London, U.K.

revised June 11, 2001; accepted June 13, 2001

Abstract

Aims To develop and validate a non-invasive method for measuring myocardial iron in order to allow diagnosis and treatment before overt cardiomyopathy and failure develops.

Methods and Results We have developed a new magnetic resonance T2-star (T2*) technique for the measurement of tissue iron, with validation to chemical estimation of iron in patients undergoing liver biopsy. To assess the clinical value of this technique, we subsequently correlated myocardial iron measured by this T2* technique with ventricular function in 106 patients with thalassaemia major. There was a significant, curvilinear, inverse correlation between iron concentration by biopsy and liver T2* (r=0·93,P <0·0001). Inter-study cardiac reproducibility was 5·0%. As myocardial iron increased, there was a progressive decline in ejection fraction (r=0·61, P<0·001). All patients with ventricular dysfunction had a myocardial T2* of <20ms. There was no significant correlation between myocardial T2* and the conventional parameters of iron status, serum ferritin and liver iron. Multivariate analysis of clinical parameters to predict the requirement for cardiac medication identified myocardial T2* as the most significant variable (odds ratio 0·79,P <0·002).

Conclusions Myocardial iron deposition can be reproducibly quantified using myocardial T2* and this is the most significant variable for predicting the need for ventricular dysfunction treatment. Myocardial iron content cannot be predicted from serum ferritin or liver iron, and conventional assessments of cardiac function can only detect those with advanced disease. Early intensification of iron chelation therapy, guided by this technique, should reduce mortality from this reversible cardiomyopathy.

Key Words: Cardiomyopathy, magnetic resonance imaging, heart failure and thalassaemia

^f1 Correspondence: Professor D. J. Pennell, Cardiovascular MR Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, U.K.

References

1. Zurlo MG, De Stefano P, Borgna-Pignatti C. Survival and causes of death in thalassaemia major. Lancet. 1989;2:27–30[ISI][Medline]
2. Olivieri NF, Nathan DG, MacMillan JH. Survival in medically treated patients with homozygous beta-thalassaemia. N Engl J Med. 1994;331:574–578[Abstract/Free Full Text]
3. Modell B, Khan M, Darlison M. Survival in beta thalassaemia major in the UK: Data from the UK Thalassaemia Register. Lancet. 2000;355:2051–2052[CrossRef][ISI][Medline]
4. Aldouri MAWB, Hoffbrand AV, Flynn DM, Ward SE, Agnew JE, Hilson AJ. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol. 1990;84:113–117[ISI][Medline]
5. Wacker PHD, Balmer-Ruedin D, Oberhansli I, Wyss M. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassaemia major. Chest. 1993;103:1276–1278[Abstract/Free Full Text]
6. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassaemia. Blood. 2000;95:1229–1236[Abstract/Free Full Text]
7. Henry WLNA, Wiener M, Miller DR, Canale VC, Piomelli S. Echocardiographic abnormalities in patients with transfusion-dependent anaemia and secondary myocardial iron deposition. Am J Med. 1978;64:547–555[CrossRef][ISI][Medline]
8. Nienhuis AW, Griffith P, Strawczynski H. Evaluation of cardiac function in patients with thalassaemia major. Ann N Y Acad Sci. 1980;344:384–396[Abstract]
9. Felker GM, Thompson RE, Hare JM. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–1084[Abstract/Free Full Text]
10. Weatherall DJ. Anaemia as a World Health Problem. 1996. p. 3463–82
11. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341:718–724[Abstract/Free Full Text]
12. Barry M, Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet. 1971;1:100–103[ISI][Medline]
13. Pattynama PM, De Roos A, Van der Wall EE, Van Voorthuisen AE. Evaluation of cardiac function with magnetic resonance imaging. Am Heart J. 1994;128:595–607[CrossRef][ISI][Medline]
14. Reeder SB, Faranesh AZ, Boxerman JL, McVeigh ER. In vivo measurement of T2* and field inhomogeneity maps in the human heart at 1.5T. Magn Reson Med. 1998;39:988–998[ISI][Medline]
15. Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M. Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol. 1996;25:172–177[CrossRef][ISI][Medline]
16. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, Kowdley KV. Quantitative study of the variability of hepatic iron concentrations. Clin Chem. 1999;45:340–346[Abstract/Free Full Text]
17. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson. 1999;1:7–21[ISI][Medline]
18. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann NY Acad Sci. 1998;850:191–201[Abstract/Free Full Text]
19. Stark DD. Hepatic iron overload: paramagnetic pathology. Radiology. 1991;179:333–335[Free Full Text]
20. Hardy PA, Henkelman RM. Transverse relaxation rate enhancement caused by magnetic particulates. Magn Reson Imaging. 1989;7:265–275[CrossRef][ISI][Medline]
21. Kaltwasser JPGR, Schalk KP, Hartl W. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol. 1990;74:360–363[ISI][Medline]
22. Gomori JMHG, Tamary H, Zandback J. Hepatic iron overload: quantitative MR imaging. Radiology. 1991;179:367–369[Abstract/Free Full Text]
23. Jensen PDJF, Christensen T, Ellegaard J. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol. 1994;87:171–184[ISI][Medline]
24. Liu PP, Henkelman M, Joshi J. Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassaemia—cardiac iron overload model. Can J Cardiol. 1996;12:155–164[ISI][Medline]
25. Johnston DL, Rice L, Vick W, Hedrick TD, Rokey R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med. 1989;87:40–47[ISI][Medline]
26. Mavrogeni SI, Gotsis ED, Markussis V. T2 relaxation time study of iron overload in b-thalassemia. MAGMA. 1998;6:7–12[Medline]
27. Gandon Y, Guyader D, Heautot JF. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology. 1994;193:533–538[Abstract/Free Full Text]
28. Ernst OSG, Bonvarlet P, Canva-Delcambre V, Paris JC, L'Hermine C. Hepatic iron overload: diagnosis and quantification with MR imaging. AJR Am J Roentgenol. 1997;168:1205–1208[Abstract/Free Full Text]
29. Bonkovsky HLRR, Cable EE, Davidoff A, Rijcken TH, Stark DD. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology. 1999;212:227–234[Abstract/Free Full Text]
30. Li D, Dhawale P, Rubin PJ, Haacke EM, Gropler RJ. Myocardial signal response to dipyridamole and dobutamine: Demonstration of the BOLD effect using a double echo gradient echo sequence. Magn Reson Med. 1996;36:16–20[ISI][Medline]
31. Wacker CM, Bock M, Hartlep AW. BOLD-MRI in 10 patients with coronary artery disease: Evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. MAGMA. 1999;8:48–54[CrossRef][Medline]
32. MacDonald RA, Mallory GK. Hemochromatosis and hemosiderosis; study of 211 autopsied cases. Arch Intern Med (Chicago). 1960;105:686–700
33. Buja LM, Roberts WC. Iron in the heart. Etiology and clinical significance. Am J Med. 1971;51:209–221[CrossRef][ISI][Medline]
34. Jessup M, Manno CS. Diagnosis and management of iron-induced heart disease in Cooley's anemia. Ann N Y Acad Sci. 1998;850:242–250[Abstract/Free Full Text]
35. Kremastinos DT, Tiniakos G, Theodorakis GN, Katritsis DG, Toutouzas PK. Myocarditis in beta-thalassaemia major. A cause of heart failure. Circulation. 1995;91:66–71[Abstract/Free Full Text]
36. Kremastinos DT, Flevari P, Spyropoulou M, Vrettou H, Tsiapras D, Stavropoulos-Giokas CG. Association of heart failure in homozygous beta-thalassaemia with the major histocompatibility complex. Circulation. 1999;100:2074–2078[Abstract/Free Full Text]
37. Economou-Petersen E, Aessopos A, Kladi A. Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood. 1998;92:3455–3459[Abstract/Free Full Text]
38. Barosi G, Arbustini E, Gavazzi A, Grasso M, Pucci A. Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients. Eur J Haematol. 1989;42:382–388[ISI][Medline]

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				L. J. Noetzli, S. M. Carson, A. S. Nord, T. D. Coates, and J. C. Wood Longitudinal analysis of heart and liver iron in thalassemia major Blood, October 1, 2008; 112(7): 2973 - 2978. [Abstract] [Full Text] [PDF]

				B. Leonardi, R. Margossian, S. D. Colan, and A. J. Powell Relationship of Magnetic Resonance Imaging Estimation of Myocardial Iron to Left Ventricular Systolic and Diastolic Function in Thalassemia J. Am. Coll. Cardiol. Img., September 1, 2008; 1(5): 572 - 578. [Abstract] [Full Text] [PDF]

				D. J. Pennell T2* Magnetic Resonance: Iron and Gold J. Am. Coll. Cardiol. Img., September 1, 2008; 1(5): 579 - 581. [Full Text] [PDF]

				T. H. Marwick and M. Schwaiger The Future of Cardiovascular Imaging in the Diagnosis and Management of Heart Failure, Part 2: Clinical Applications Circ Cardiovasc Imaging, September 1, 2008; 1(2): 162 - 170. [Full Text] [PDF]

				A. A. Di Tucci, G. Matta, S. Deplano, A. Gabbas, C. Depau, D. Derudas, G. Caocci, A. Agus, and E. Angelucci Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias Haematologica, September 1, 2008; 93(9): 1385 - 1388. [Abstract] [Full Text] [PDF]

				L. Anderson and D. Pennell The role of endomyocardial biopsy in the management of cardiovascular disease: a Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Eur. Heart J., July 1, 2008; 29(13): 1696 - 1696. [Full Text] [PDF]

				E. Ladich and R. Virmani The role of endomyocardial biopsy in the management of cardiovascular disease: a Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology: reply Eur. Heart J., July 1, 2008; 29(13): 1696 - 1697. [Full Text] [PDF]

				J. C. Wood, R. Origa, A. Agus, G. Matta, T. D. Coates, and R. Galanello Onset of cardiac iron loading in pediatric patients with thalassemia major Haematologica, June 1, 2008; 93(6): 917 - 920. [Abstract] [Full Text] [PDF]

				E. Vichinsky Oral Iron Chelators and the Treatment of Iron Overload in Pediatric Patients With Chronic Anemia Pediatrics, June 1, 2008; 121(6): 1253 - 1256. [Full Text] [PDF]

				E. Angelucci, G. Barosi, C. Camaschella, M. D. Cappellini, M. Cazzola, R. Galanello, M. Marchetti, A. Piga, and S. Tura Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders Haematologica, May 1, 2008; 93(5): 741 - 752. [Abstract] [Full Text] [PDF]

				D. P. O'Regan, M. F. Callaghan, M. Wylezinska-Arridge, J. Fitzpatrick, R. P. Naoumova, J. V. Hajnal, and S. A. Schmitz Liver Fat Content and T2*: Simultaneous Measurement by Using Breath-hold Multiecho MR Imaging at 3.0 T--Feasibility Radiology, May 1, 2008; 247(2): 550 - 557. [Abstract] [Full Text] [PDF]

				K. Aghasadeghi and A. Aslani Differentiation of Ischemic and Dilated Cardiomyopathy on Electrocardiograms Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 103 - 106. [Abstract] [Full Text] [PDF]

				T. Germans and A. C van Rossum The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy Heart, April 1, 2008; 94(4): 510 - 518. [Full Text] [PDF]

				S. V. Raman, M. W. Winner III, T. Tran, M. Velayutham, O. P. Simonetti, P. B. Baker, J. Olesik, B. McCarthy, A. K. Ferketich, and J. L. Zweier In Vivo Atherosclerotic Plaque Characterization Using Magnetic Susceptibility Distinguishes Symptom-Producing Plaques J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 49 - 57. [Abstract] [Full Text] [PDF]

				U Sechtem, H Mahrholdt, and H Vogelsberg Cardiac magnetic resonance in myocardial disease Heart, December 1, 2007; 93(12): 1520 - 1527. [Abstract] [Full Text] [PDF]

				W. O. Ntim, B. Upadhya, and J. Cruz Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease J. Am. Coll. Cardiol., July 24, 2007; 50(4): 378 - 378. [Full Text] [PDF]

				J.-I. Henter and J. Karlen Fatal agranulocytosis after deferiprone therapy in a child with Diamond-Blackfan anemia Blood, June 15, 2007; 109(12): 5157 - 5159. [Abstract] [Full Text] [PDF]

				A. Aessopos, M. Kati, and D. Farmakis Heart disease in thalassemia intermedia: a review of the underlying pathophysiology Haematologica, May 1, 2007; 92(5): 658 - 665. [Abstract] [Full Text] [PDF]

				M.A. Tanner, R. Galanello, C. Dessi, G.C. Smith, M.A. Westwood, A. Agus, M. Roughton, R. Assomull, S.V. Nair, J.M. Walker, et al. A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance Circulation, April 10, 2007; 115(14): 1876 - 1884. [Abstract] [Full Text] [PDF]

				A. Aessopos, C. Fragodimitri, F. Karabatsos, A. Hatziliami, J. Yousef, A. Giakoumis, A. Dokou, E. D. Gotsis, V. Berdoukas, and M. Karagiorga Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia Haematologica, January 1, 2007; 92(1): 131 - 132. [Abstract] [Full Text] [PDF]

				D. J. Pennell, V. Berdoukas, M. Karagiorga, V. Ladis, A. Piga, A. Aessopos, E. D. Gotsis, M. A. Tanner, G. C. Smith, M. A. Westwood, et al. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis Blood, May 1, 2006; 107(9): 3738 - 3744. [Abstract] [Full Text] [PDF]

				E. J. Neufeld Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions Blood, May 1, 2006; 107(9): 3436 - 3441. [Abstract] [Full Text] [PDF]

				A. Winder, E. Konen, T. Kushnir, M. Leiba, and E. Rachmilewitz No Evidence for Iron Overload in the Heart of Multitransfused Elderly Patients with Sideroblastic Anemia (RARS) Measured by T2* MRI. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 2536 - 2536. [Abstract]

				J. C. Wood, C. Enriquez, N. Ghugre, J. M. Tyzka, S. Carson, M. D. Nelson, and T. D. Coates MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients Blood, August 15, 2005; 106(4): 1460 - 1465. [Abstract] [Full Text] [PDF]

				J. C. Wood, M. Otto-Duessel, M. Aguilar, H. Nick, M. D. Nelson, T. D. Coates, H. Pollack, and R. Moats Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy Circulation, July 26, 2005; 112(4): 535 - 543. [Abstract] [Full Text] [PDF]

				O. Papakonstantinou, T. G. Maris, S. Kostaridou, V. Ladis, A. Vasiliadou, and N. C. Gourtsoyiannis Abdominal Lymphadenopathy in {beta}-Thalassemia: MRI Features and Correlation with Liver Iron Overload and Posttransfusion Chronic Hepatitis C Am. J. Roentgenol., July 1, 2005; 185(1): 219 - 224. [Abstract] [Full Text] [PDF]

				C. J. Soriano, F. Ridocci, J. Estornell, J. Jimenez, V. Martinez, and J. A. De Velasco Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance J. Am. Coll. Cardiol., March 1, 2005; 45(5): 743 - 748. [Abstract] [Full Text] [PDF]

				D. A. Bluemke and R. P. Liddell Can MR Imaging Provide a Noninvasive "Biopsy" of the Heart to Measure Iron Levels? Radiology, March 1, 2005; 234(3): 647 - 648. [Full Text] [PDF]

				Z. J. Wang, L. Lian, Q. Chen, H. Zhao, T. Asakura, and A. R. Cohen 1/T2 and Magnetic Susceptibility Measurements in a Gerbil Cardiac Iron Overload Model Radiology, March 1, 2005; 234(3): 749 - 755. [Abstract] [Full Text] [PDF]

				J. B. Porter Liver iron measurement by MRI Blood, January 15, 2005; 105(2): 437 - 438. [Full Text] [PDF]

				T. G. St. Pierre, P. R. Clark, W. Chua-anusorn, A. J. Fleming, G. P. Jeffrey, J. K. Olynyk, P. Pootrakul, E. Robins, and R. Lindeman Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance Blood, January 15, 2005; 105(2): 855 - 861. [Abstract] [Full Text] [PDF]

				D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF]

				B. A. Davis, C. O'Sullivan, P. H. Jarritt, and J. B. Porter Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major Blood, July 1, 2004; 104(1): 263 - 269. [Abstract] [Full Text] [PDF]

				E. Neufeld Myocardial iron measurements by MRI: getting to the heart of the matter Blood, March 1, 2004; 103(5): 1571 - 1571. [Full Text] [PDF]

				J. C. Wood, J. M. Tyszka, S. Carson, M. D. Nelson, and T. D. Coates Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease Blood, March 1, 2004; 103(5): 1934 - 1936. [Abstract] [Full Text] [PDF]

				A. R. Cohen, R. Galanello, D. J. Pennell, M. J. Cunningham, and E. Vichinsky Thalassemia Hematology, January 1, 2004; 2004(1): 14 - 34. [Abstract] [Full Text] [PDF]

				J.A. McCrohon, J.C.C. Moon, S.K. Prasad, W.J. McKenna, C.H. Lorenz, A.J.S. Coats, and D.J. Pennell Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance Circulation, July 8, 2003; 108(1): 54 - 59. [Abstract] [Full Text] [PDF]

				A. V. Hoffbrand, A. Cohen, and C. Hershko Role of deferiprone in chelation therapy for transfusional iron overload Blood, July 1, 2003; 102(1): 17 - 24. [Full Text] [PDF]

				P. D. Jensen, F. T. Jensen, T. Christensen, H. Eiskjaer, U. Baandrup, and J. L. Nielsen Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool Blood, June 1, 2003; 101(11): 4632 - 4639. [Abstract] [Full Text] [PDF]

				C. M. Wacker, A. W. Hartlep, S. Pfleger, L. R. Schad, G. Ertl, and W. R. Bauer Susceptibility-sensitive magnetic resonance imaging detects human myocardium supplied by a stenotic coronary artery without a contrast agent J. Am. Coll. Cardiol., March 5, 2003; 41(5): 834 - 840. [Abstract] [Full Text] [PDF]

				A.V. Hoffband A sensitive test for early myocardial iron loading Eur. Heart J., January 1, 2003; 24(1): 26 - 27. [Full Text] [PDF]

				M Vogel, L.J Anderson, S Holden, J.E Deanfield, D.J Pennell, and J.M Walker Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload Eur. Heart J., January 1, 2003; 24(1): 113 - 119. [Abstract] [Full Text] [PDF]

				E. Beutler, A. V. Hoffbrand, and J. D. Cook Iron Deficiency and Overload Hematology, January 1, 2003; 2003(1): 40 - 61. [Abstract] [Full Text] [PDF]

				G. M. Brittenham and D. G. Badman Noninvasive measurement of iron: report of an NIDDK workshop Blood, January 1, 2003; 101(1): 15 - 19. [Abstract] [Full Text] [PDF]

				A.V. Hoffbrand Diagnosing myocardial iron overload Eur. Heart J., December 1, 2001; 22(23): 2140 - 2141. [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed